Review

Published on 19 Sep 2018

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

in Pharmacology of Anti-Cancer Drugs

Peixin Dong
Ying Xiong
Junming Yue
Sharon J. B. Hanley
Hidemichi Watari

Frontiers in Oncology

doi 10.3389/fonc.2018.00386

23,936 views
242 citations

Mini Review

Published on 25 Jul 2018

Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy

in Pharmacology of Anti-Cancer Drugs

Sebastian Kobold
Stanislav Pantelyushin
Felicitas Rataj
Johannes vom Berg

Frontiers in Oncology

doi 10.3389/fonc.2018.00285

22,611 views
83 citations

Case Report

Published on 24 Jul 2018

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening

in Pharmacology of Anti-Cancer Drugs

Chi C. Tong
Ching W. Lam
Ka O. Lam
Victor H. F. Lee
Mai-Yee Luk

Frontiers in Oncology

doi 10.3389/fonc.2018.00279

5,412 views
19 citations

Review

Published on 06 Jul 2018

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

in Pharmacology of Anti-Cancer Drugs

Peixin Dong
Ying Xiong
Junming Yue
Sharon J. B. Hanley
Hidemichi Watari

Frontiers in Oncology

doi 10.3389/fonc.2018.00264

23,396 views
95 citations

Original Research

Published on 04 Jul 2018

Single-Cell Tracking of A549 Lung Cancer Cells Exposed to a Marine Toxin Reveals Correlations in Pedigree Tree Profiles

in Pharmacology of Anti-Cancer Drugs

Mónica Suárez Korsnes
Reinert Korsnes

Frontiers in Oncology

doi 10.3389/fonc.2018.00260

8,296 views
10 citations

Case Report

Published on 05 Jun 2018

Immunemodulatory Effects of 5-Azacitidin Through Expansion of Functional Regulatory T Cells on Paraneoplastic Inflammation Associated With Myelodysplastic Syndromes: A Case Report

in Pharmacology of Anti-Cancer Drugs

Kentaro Serizawa
Hirokazu Tanaka
Yasuyoshi Morita
Takahide Taniguchi
Takashi Ashida
Itaru Matsumura

Frontiers in Oncology

doi 10.3389/fonc.2018.00204

2,243 views
5 citations

Review

Published on 18 May 2018

Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions

in Pharmacology of Anti-Cancer Drugs

Christian M. Schürch

Frontiers in Oncology

doi 10.3389/fonc.2018.00152

14,127 views
36 citations

Review

Published on 18 May 2018

Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy

in Pharmacology of Anti-Cancer Drugs

Tareq Saleh
Liliya Tyutynuk-Massey
Emmanuel K. Cudjoe
Michael O. Idowu
Joseph W. Landry
David A. Gewirtz

Frontiers in Oncology

doi 10.3389/fonc.2018.00164

12,090 views
70 citations

Review

Published on 22 Mar 2018

Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice

in Pharmacology of Anti-Cancer Drugs

Ronald Anderson
Bernardo L. Rapoport

Frontiers in Oncology

doi 10.3389/fonc.2018.00080

6,031 views
39 citations

Original Research

Published on 11 Dec 2017

Evaluation of Apoptosis and Autophagy Inducing Potential of Berberis aristata, Azadirachta indica, and Their Synergistic Combinations in Parental and Resistant Human Osteosarcoma Cells

in Pharmacology of Anti-Cancer Drugs

Pracheta Sengupta
Sukanya Raman
Rajdeep Chowdhury
K. Lohitesh
Heena Saini
Sudeshna Mukherjee
Atish Paul

Frontiers in Oncology

doi 10.3389/fonc.2017.00296

5,112 views
20 citations

General Commentary

Published on 21 Nov 2017

Commentary: Molecular Machines Open Cell Membranes

in Pharmacology of Anti-Cancer Drugs

Shankargouda Patil
A. Thirumal Raj

Frontiers in Oncology

doi 10.3389/fonc.2017.00277

2,373 views
2 citations

Original Research

Published on 27 Jun 2017

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma

in Pharmacology of Anti-Cancer Drugs

Hai Wei Wu
Chao Liu
Xuan Wang
Ling Zhang
Weien Yuan
Jia Wei Zheng
Li Xin Su
Xin Dong Fan

Frontiers in Oncology

doi 10.3389/fonc.2017.00137

23,072 views
24 citations

Original Research

Published on 10 Jan 2017

Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study

in Pharmacology of Anti-Cancer Drugs

Raghav Sundar
Aishwarya Bandla
Stacey Sze Hui Tan
Lun-De Liao
Nesaretnam Barr Kumarakulasinghe
Anand D. Jeyasekharan
Samuel Guan Wei Ow
Jingshan Ho
David Shao Peng Tan
Joline Si Jing Lim

Frontiers in Oncology

doi 10.3389/fonc.2016.00274

10,465 views
42 citations

Case Report

Published on 07 Oct 2016

Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature

in Pharmacology of Anti-Cancer Drugs

Martin Uhl
Stefan Schwab
Thomas Efferth

Frontiers in Oncology

doi 10.3389/fonc.2016.00204

7,524 views
26 citations

Review

Published on 10 May 2016

Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal

in Pharmacology of Anti-Cancer Drugs

Fabrizio Marcucci
Cristiano Rumio
François Lefoulon

Frontiers in Oncology

doi 10.3389/fonc.2016.00115

9,355 views
41 citations

Original Research

Published on 05 Jan 2016

Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds

in Pharmacology of Anti-Cancer Drugs

Farid Khallouki
Philippe de Medina
Stéphanie Caze-Subra
Kerstin Bystricky
Patrick Balaguer
Marc Poirot
Sandrine Silvente-Poirot

Frontiers in Oncology

doi 10.3389/fonc.2015.00287

8,718 views
33 citations

Navigation group

Articles

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

Single-Cell Tracking of A549 Lung Cancer Cells Exposed to a Marine Toxin Reveals Correlations in Pedigree Tree Profiles

Immunemodulatory Effects of 5-Azacitidin Through Expansion of Functional Regulatory T Cells on Paraneoplastic Inflammation Associated With Myelodysplastic Syndromes: A Case Report

Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions

Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy

Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice

Evaluation of Apoptosis and Autophagy Inducing Potential of Berberis aristata, Azadirachta indica, and Their Synergistic Combinations in Parental and Resistant Human Osteosarcoma Cells

Commentary: Molecular Machines Open Cell Membranes

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma

Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study

Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature

Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal

Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds